{
    "pmcid": "10167778",
    "qa_pairs": {
        "What animal model was proposed as a new source for VNAR discovery targeting SARS-CoV-2?": [
            "Banded houndshark",
            "Nurse shark",
            "White-spotted bamboo shark",
            "Camelid"
        ],
        "What feature of CoV2NAR-1 suggests its potential for therapeutic application?": [
            "Monomeric and thermally stable with retained binding affinity after heat treatment",
            "High immunogenicity and complex production process",
            "Limited stability and specificity for non-cryptic epitopes",
            "Inability to bind to the ACE2 binding site"
        ],
        "What was the primary method used to isolate VNAR clones from the banded houndshark?": [
            "Phage display immune library",
            "CRISPR-Cas9 gene editing",
            "Hybridoma technology",
            "Yeast two-hybrid screening"
        ],
        "Which SARS-CoV-2 variants did CoV2NAR-1 show strong binding affinity towards?": [
            "Alpha, Beta, and Delta",
            "Gamma, Mu, and Lambda",
            "Omicron, Eta, and Iota",
            "Zeta, Theta, and Kappa"
        ],
        "Which VNAR clone was identified as having the highest binding affinity to the SARS-CoV-2 RBD?": [
            "CoV2NAR-1",
            "CoV2NAR-2",
            "CoV2NAR-3",
            "CoV2NAR-4"
        ]
    }
}